We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Grants Designation for Treatment of Antibiotic-Associated Diarrhea
FDA Grants Designation for Treatment of Antibiotic-Associated Diarrhea
FDA granted a Qualified Infectious Disease Product designation to MGB-BP-3, developed by MGB Biopharma, for the treatment of Clostridium difficile-associated diarrhea.